RSNN Workshop 2022 - Patient preferences: towards a more structural incorporation in the regulatory pathway

Patient preferences are of growing interest in the medical product life cycle and are used among others in the decision-making of drugs, benefit-risk trade-offs, health technology assessments, clinical trial designs and post-marketing risk assessments.

In this RSNN workshop we want to explore how to improve the incorporation of patient preferences within the regulatory framework, and especially address how patient preferences can be of most value for regulators, patients, industries, HTA bodies, and other stakeholders. Discussions with the audience from various backgrounds are a critical element in this respect. A detailed program will be published soon on the event site.

For more information and registration, please visit: https://events.rsnn.nl/rsnn-workshop/